Research

Energy balance

Metabolic dysfunction-associated steatohepatitis is now a leading indication for liver transplantation.

Healthcare providers should consider MASLD as a critical factor in liver transplant evaluations.

StrongSupportsmedium confidence
Metabolic dysfunction-associated steatohepatitis is now a leading indication for liver transplantation.
Jessica P.E. Davis et al. · Liver Transplantation · 2025

Why this rating

The claim is based on current clinical data.

Source

Management of obesity in liver transplant candidates and recipients: Rethinking the false dichotomy between pharmacotherapy and surgical intervention

Jessica P.E. Davis et al. · Liver Transplantation · 2025

DOI 10.1097/lvt.0000000000000645

reviewCited 5×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →